Stay updated with breaking news from Michael Sela. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stanford-based, Haifa-born Prof. Mochly-Rosen attends international conference at Haifa’s Rambam Medical Center, where she spoke about translational medicine and medical innovations.
His chance discovery that injections of synthetic proteins helped suppress the symptoms of MS led to the development of Copaxone
Marking World MS day this week, what do we know about the terrible disease? How can it be managed and is there a possibility of developing a vaccine against it?
Past president of Weizmann, Israel Prize laureate Michael Sela co-invented multiple sclerosis drug Copaxone.
What is a breakthrough in cancer research? It is a new piece of a puzzle made up of a million pieces. It may, however, be a piece that allows a picture to start emerging – one that lets us see the shape of the next piece needed to fill in more of the puzzle, or start making changes to rearrange the picture from one of cancerous growth to one of normalcy.